BNTXBioNTech SERunning, no new patients
A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer
Colorectal Cancer Stage II · Colorectal Cancer Stage III
0Calmworry score, out of 100
No strong warning signs right now. The score counts warning signs; it is not a prediction.
Why this score
No warning signs right now. That's why the score is 0.
Score over time
- Stage
- Phase 2
- Patients
- 327 (planned)
- Started
- Mar 8, 2021
- Main results expected
- Nov 2026
- Fully finished
- Nov 2026
- Results posted
- not yet
What counts as success
The trial's main goal(s), called the “primary outcome.”
Disease-free survival (DFS)
Measured over: Through study completion, up to 5 years
Changes Tremor has spotted
No changes since Tremor started watching this trial.
Show details (technical version)
Score inputs
- none
Raw record changes
- none yet
Trial ID NCT04486378 · record last updated 2026-10-07 · checked 2026-11-09 15:47 UTC